The reported statements, read against the company's own industry.
Financials view
Market Capitalization
463.75BKRW
334.16M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
30.61BKRW
22.06M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-14.12%
vs Medical Care Facilities peers
Updated Aug 20, 2026
52-Week Change
97.92%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
463.75BKRW
334.16M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
474.33BKRW
341.78M · vs all stocks (USD)
Updated Aug 20, 2026
Price to Sales (TTM)
15.43x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Price to Book (MRQ)
40.98x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Enterprise to Revenue
15.50x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Gross Margin
58.42%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Profit Margin
-14.12%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Operating Margin
-27.32%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Return on Assets (TTM)
-1.83%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Return on Equity (TTM)
-24.63%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Revenue (TTM)
30.61BKRW
22.06M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
2.07KKRWUpdated Aug 20, 2026
Quarterly Revenue Growth
118.10%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Gross Profit (TTM)
18.16BKRW
13.09M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
1.77BKRW
1.28M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-4.32BKRW
-3.11M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
118.08%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
-21.49BKRW
-15.49M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
-4.67BKRW
-3.36M · vs all stocks (USD)
Updated Aug 20, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Minority Interest (Equity)
-4.84MKRWFY2025 · Dec 31, 2025
Revenue
26.25BKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
10.56BKRWFY2025 · Dec 31, 2025
Gross Profit
15.69BKRWFY2025 · Dec 31, 2025
Operating Income
452.88MKRW
326.33K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.92BKRWFY2025 · Dec 31, 2025
Income Tax Expense
885.21MKRWFY2025 · Dec 31, 2025
Net Income
-2.80BKRWFY2025 · Dec 31, 2025
EBIT
2.65BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.77BKRWFY2025 · Dec 31, 2025
Research & Development
1.02BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
6.87BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
584.89MKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
380.67MKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.57BKRWFY2025 · Dec 31, 2025
EPS (Basic)
-222.00KRWFY2025 · Dec 31, 2025
EPS (Diluted)
-222.00KRWFY2025 · Dec 31, 2025
Basic Shares Outstanding
12.82MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
12.82MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-2.80BKRWFY2025 · Dec 31, 2025
Minority Interests (P&L)
-40.46MKRWFY2025 · Dec 31, 2025
Operating Cash Flow
-19.63BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-19.79BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
31.05BKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-2.80BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
-436.32MKRWFY2025 · Dec 31, 2025
Other Non-cash Items
4.31BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-12.44BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-8.26BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-160.34MKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-372.93MKRWFY2025 · Dec 31, 2025
Net Acquisitions
-500.00MKRWFY2025 · Dec 31, 2025
Purchase of Investments
-111.17MKRWFY2025 · Dec 31, 2025
Sale of Investments
353.20MKRWFY2025 · Dec 31, 2025
Other Investing Activity
-10.00KRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
-418.30MKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
30.00BKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-9.51BKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-3.16BKRWFY2025 · Dec 31, 2025
Other Financing Charges
-1.17BKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
37.31BKRWFY2025 · Dec 31, 2025
Shares Outstanding
15.69MSharesUpdated Aug 20, 2026
Float Shares
12.18MSharesUpdated Aug 20, 2026
% Held by Insiders
23.53%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
3.38%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
78.87BKRW
56.83M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
5.04KKRWUpdated Aug 20, 2026
Total Debt (MRQ)
25.77BKRW
18.57M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.7577x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Current Ratio (MRQ)
1.30x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
721.15KRWUpdated Aug 20, 2026
Total Assets
55.03BKRW
39.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
52.49BKRWFY2025 · Dec 31, 2025
Total Liabilities
43.47BKRWFY2025 · Dec 31, 2025
Total Non-current Assets
2.54BKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.87BKRWFY2025 · Dec 31, 2025
Total Current Liabilities
40.61BKRWFY2025 · Dec 31, 2025
Cash Equivalents
31.05BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
31.05BKRWFY2025 · Dec 31, 2025
Other Short-term Investments
1.02BKRWFY2025 · Dec 31, 2025
Accounts Receivable
14.27BKRWFY2025 · Dec 31, 2025
Inventory
2.17BKRWFY2025 · Dec 31, 2025
Accounts Payable
2.09BKRWFY2025 · Dec 31, 2025
Short-term Debt
26.00BKRWFY2025 · Dec 31, 2025
Other Current Liabilities
270.00KRWFY2025 · Dec 31, 2025
Long-term Debt
146.77MKRWFY2025 · Dec 31, 2025
Other Non-current Liabilities
330.00KRWFY2025 · Dec 31, 2025
Common Stock (Book)
7.83BKRWFY2025 · Dec 31, 2025
Retained Earnings
-109.96BKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
11.55BKRW
8.33M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.12KKRWUpdated Aug 20, 2026
52-Week High
153.80KKRWUpdated Aug 20, 2026
52-Week Change
97.92%
vs all stocks
Updated Aug 20, 2026
50-Day MA
42.07KKRWUpdated Aug 20, 2026
200-Day MA
65.79KKRWUpdated Aug 20, 2026
Avg 10-Day Volume
204.87KSharesUpdated Aug 20, 2026
Avg 30-Day Volume
323.66KSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-222.00KRWUpdated Aug 20, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -27.3%, lower than 95% of its Medical Care Facilities peers (median 11%)Significant
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedOperating Income Growing With Multi-Year Revenue Growth
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedOperating Income Growing With Multi-Year Revenue Growth
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedOperating Income Growing With Multi-Year Revenue Growth